W
William W. Busse
Researcher at University of Wisconsin-Madison
Publications - 740
Citations - 62685
William W. Busse is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Asthma & Eosinophil. The author has an hindex of 115, co-authored 697 publications receiving 56703 citations. Previous affiliations of William W. Busse include National Institutes of Health & University at Buffalo.
Papers
More filters
Journal ArticleDOI
Facial edema and eosinophilia. Evidence for eosinophil degranulation.
Vanee Songsiridej,Margot S. Peters,Philippe J. Dor,Steven J. Ackerman,Gerald J. Gleich,William W. Busse +5 more
TL;DR: Immunofluorescence staining showed extracellular localization of the major basic protein within the dermis, similar to that previously shown in chronic urticaria and the recently described syndrome of episodic angioedema with eosinophilia, providing further evidence that degranulation of eOSinophils occurs in the skin.
Journal ArticleDOI
The US Food and Drug Administration and long-acting β2-agonists: The importance of striking the right balance between risks and benefits of therapy?
TL;DR: On February 18, 2010, exercising new authority under the FDA Amendments Act of 2007, the FDA announced a set of updated recommendations that subsequently will require a class-labeling change on all United States–manufactured long-acting b2agonists (LABAs).
Journal ArticleDOI
Obstruction phenotype as a predictor of asthma severity and instability in children.
Ronald L. Sorkness,Edward M. Zoratti,Meyer Kattan,Peter J. Gergen,Michael D. Evans,Cynthia M. Visness,Michelle A. Gill,Gurjit K. Khurana Hershey,Carolyn M. Kercsmar,Andrew H. Liu,George T. O'Connor,Jacqueline A. Pongracic,Dinesh K. Pillai,Christine A. Sorkness,Alkis Togias,Robert A. Wood,William W. Busse +16 more
TL;DR: A Trpg and A Limit patterns of obstruction, as defined by using routine spirometric measurements, can identify obstruction phenotypes that are indicators of risk for asthma severity and instability.
Journal ArticleDOI
Use of ipratropium bromide in asthma: Results of a multi-clinic study
William W. Storms,Stephen F. Bodman,Robert A. Nathan,William W. Busse,Robert K. Bush,Constantine J. Falliers,John D. O'Hollaren,John G. Weg +7 more
TL;DR: Comparison of the areas under the curves for the two drugs showed that there was no statistical difference between ipratropium or metaproterenol, and both drugs were equally effective bronchodilators.